DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Multi-Organ Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Multi-Organ Failure ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin where reactions include multi-organ failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female, weighing 115.0 kg (253.0 pounds)

Reactions: Multi-Organ Failure, Emphysematous Cystitis, Urinary Tract Infection, Sepsis, Ascites

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2010-12-23
    End date: 2011-01-13

Pegasys
    Start date: 2010-11-05

Ribavirin
    Indication: Hepatitis C
    Start date: 2010-11-05

Other drugs received by patient: Lisinopril; Glipizide; Fluoxetine HCL; Spironolactone; Propranolol; Omeprazole; Glipizide; Fosamax



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02

Patient:

Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Pegasys
    Dosage: 180 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix



Possible Ribavirin side effects in male

Reported by a physician from France on 2012-06-12

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Multi-Organ Failure, Renal Failure, Vomiting, Food Intolerance, Nausea, Urinary Tract Infection, Gastroenteritis Staphylococcal, Acidosis, Septic Shock, Abdominal Pain Upper

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-04-22
    End date: 2011-05-15

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2011-04-22
    End date: 2011-05-15

Duragesic-100
    Indication: Pain

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-04-22
    End date: 2011-05-15

Other drugs received by patient: Levothyroxine Sodium; Acetaminophen; Aluminum Hydroxide and Magnesium Trisilicate; Diamicron; Temazepam; Metformin HCL; Dicetel



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-05-25

Patient: female, weighing 115.0 kg (253.0 pounds)

Reactions: Death, Multi-Organ Failure, Emphysematous Cystitis, Urinary Tract Infection, Sepsis, Ascites

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Start date: 2010-11-05

Ribavirin
    Indication: Hepatitis C
    Start date: 2010-11-05

Pegasys
    Indication: Hepatitis C
    Start date: 2010-12-23
    End date: 2011-01-13

Other drugs received by patient: Lisinopril; Glipizide; Propranolol; Spironolactone; Glipizide; Fluoxetine; Fosamax



Possible Ribavirin side effects in male

Reported by a physician from China on 2012-05-22

Patient: male

Reactions: Multi-Organ Failure, Meningitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Azithromycin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Cefuroxime
    Dosage: .8g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Blinded Vaccine
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-12-03
    End date: 2010-12-03

Ribavirin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11



Possible Ribavirin side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-09

Patient: 59 year old male

Reactions: Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Pegasys
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Eprex; Nadol; Metformin HCL; Diazepam; Lasix



Possible Ribavirin side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-08

Patient: 56 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Multi-Organ Failure, Rhabdomyolysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Janumet
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-04-10

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Other drugs received by patient: Epoetin Beta



Possible Ribavirin side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-01

Patient: 56 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Multi-Organ Failure, Rhabdomyolysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Janumet
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-04-10

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Other drugs received by patient: Epoetin Beta



Possible Ribavirin side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-30

Patient: 56 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Multi-Organ Failure, Rhabdomyolysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Janumet
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-04-10

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Other drugs received by patient: Epoetin Beta



Possible Ribavirin side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-11

Patient: 59 year old male

Reactions: Confusional State, Anaemia, Condition Aggravated, Ketoacidosis, Somnolence, Ascites, Loss of Consciousness, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Pegasys
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Nadol; Lasix; Diazepam; Eprex; Metformin HCL



Possible Ribavirin side effects in 64 year old male

Reported by a physician from Spain on 2012-04-11

Patient: 64 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Hepatic Function Abnormal, Disseminated Intravascular Coagulation, Disorientation, Somnolence, Multi-Organ Failure, Asterixis, Hepatic Encephalopathy, Ventricular Tachyarrhythmia, Acute Respiratory Failure, Metabolic Acidosis, Dyspnoea, Hypotension, Anaemia, General Physical Health Deterioration, Lobar Pneumonia, Haemodialysis, Ascites, Renal Failure, Treatment Failure, Cardiac Arrest, Purulent Discharge

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-03-18

Ribavirin
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-03-18

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-10
    End date: 2012-03-18

Other drugs received by patient: Propranolol; Amiloride Hydrochloride



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-10

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Anaemia, Ketoacidosis, Loss of Consciousness, Ascites, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Victrelis
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-12
    End date: 2012-03-13

Other drugs received by patient: Nadolol; Lasix; Metformin HCL; Eprex; Glyburide; Spironolactone; Diazepam



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-06

Patient: 57 year old female

Reactions: Pulmonary Necrosis, Metabolic Acidosis, Continuous Haemodiafiltration, Hepatic Failure, Treatment Noncompliance, Lung Abscess, Ascites, Multi-Organ Failure, Renal Failure, Dialysis, Respiratory Failure, Pneumonia Staphylococcal, Skin Infection, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2011-01-30

Boceprevir (Sch-503034)
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Ribavirin
    Dosage: 400 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible Ribavirin side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-04

Patient: 59 year old male

Reactions: Anaemia, Ketoacidosis, Loss of Consciousness, Ascites, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg, q8h, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Ribavirin
    Dosage: 1000 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Pegasys
    Dosage: 180 mcg, qw, sc
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Eprex; Diazepam; Lasix; Nadol; Glyburide



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-04

Patient: male

Reactions: Multi-Organ Failure, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Victrelis
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-28

Patient: male

Reactions: Anaemia, Ketoacidosis, Loss of Consciousness, Ascites, Haemoglobin Decreased, Multi-Organ Failure, Platelet Count Decreased, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Victrelis
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-12
    End date: 2012-03-13

Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Eprex; Nadolol; Diazepam



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-27

Patient: male

Reactions: Multi-Organ Failure, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Victrelis
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-16

Patient: 57 year old female

Reactions: Hepatic Failure, Treatment Noncompliance, Oral Herpes, Lung Abscess, Multi-Organ Failure, Pneumonia Staphylococcal, Immunosuppression, Metabolic Acidosis, Pulmonary Necrosis, International Normalised Ratio Increased, Ascites, Haemodialysis, Renal Failure, Staphylococcal Infection, Respiratory Failure, Septic Shock, Infection Susceptibility Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Boceprevir (Sch-503034)
    Dosage: 800 mg; tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Ribavirin
    Dosage: 400 mg; bid; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

PEG-Intron
    Dosage: 100 mcg; qw; sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-12

Patient: 57 year old female

Reactions: Pneumonia, Metabolic Acidosis, Necrosis, Hepatic Failure, Multi-Organ Failure, Renal Failure, Dialysis, Abscess, Pneumonia Staphylococcal, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Boceprevir (Sch-503034)
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Ribavirin
    Dosage: 400mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible Ribavirin side effects in male

Reported by a physician from China on 2012-01-04

Patient: male

Reactions: Multi-Organ Failure, Meningitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cefuroxime
    Dosage: .8g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Blinded Vaccine
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-12-03
    End date: 2010-12-03

Ribavirin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Azithromycin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11



Possible Ribavirin side effects in male

Reported by a physician from China on 2011-12-28

Patient: male

Reactions: Mydriasis, Sudden Death, Multi-Organ Failure, Overdose, Cyanosis, Pulse Absent, Nervous System Disorder, Meningitis Bacterial, Respiratory Arrest, Meningitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Azithromycin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Blinded Vaccine
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-12-03
    End date: 2010-12-03

Cefuroxime
    Dosage: .8g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Ribavirin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11



Possible Ribavirin side effects in male

Reported by a physician from China on 2011-12-22

Patient: male

Reactions: Multi-Organ Failure, Meningitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Blinded Vaccine
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-12-03
    End date: 2010-12-03

Azithromycin
    Dosage: .1g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

Cefuroxime
    Dosage: .8g per day
    Indication: Meningitis
    Start date: 2011-07-11
    End date: 2011-07-11

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014